Peptides you can cite in a paper.
Lyochem synthesizes characterised research peptides for biomedical labs, biotech R&D, and CROs. Every lot ships with its own analytical packet: RP-HPLC chromatogram, ESI-MS identity, and MS/MS sequence on request — methodology, not marketing.
RP-HPLC · Illustrative lot
BPC-157 · Lot LC-26-A0517
Sequence
15-mer
MW
1419.55
CAS
137525-51-0
ESI-MS
1420.6
Illustrative HPLC trace · BPC-157 lot LC-26-A0517 · representative of a ≥99 % released lot
Analytical scope on every lot
- ≥98.5% HPLC
- Mass-Spec Confirmed
- Sequence-Verified
- Stability-Tested
- USP / EP / ICH Aligned
- Per-Lot Data Packet
Methods aligned with USP ⟨621⟩ · ⟨1225⟩ · ICH Q2 · EP cosmetic-ingredient framework
Browse by Research Area
Eight research families, one analytical standard.
From GH-axis pituitary work to Khavinson short bioregulators, browse the catalogue by the experimental context a working lab buyer thinks in.
Largest research cluster
13 SKUsGH-Axis Peptides
CJC-1295, Sermorelin, Ipamorelin, GHRP-2/6, IGF-1 LR3, MGF, Tesamorelin, HGH and HGH-fragment 176-191. GHRH-receptor agonists, GHSR (ghrelin-receptor) agonists, and IGF-axis reagents for somatotropic-pathway research.
Includes AOD9604 · CJC-1295
Browse gh-axis peptides
Most-cited cluster
10 SKUsCognitive & Neuropeptides
Semax, Selank, DSIP, Cerebrolysin, P21, Pinealon, Melatonin, VIP, Oxytocin, Kisspeptin-10. Neuropeptide reagents for cognitive, mood, sleep-architecture, social-behaviour, and HPG-axis research.
Includes Cerebrolysin · DSIP
Browse cognitive & neuropeptides
Custom Synthesis
Sequence not in the catalogue? We'll synthesise it.
Fmoc-SPPS up to ~50 residues, modifications (PEGylation, fluorophore / isotope labelling), milligram-to-multi-gram scale. Two-signature release on every custom project — synthesis chemist + analytical lead.
Most-cited research peptides
Browse standards. Sortable by purity, MW, or vial size.
Twelve of the 57 characterised reference standards in the Lyochem library. Every entry ships with the same lot-specific analytical packet (RP-HPLC + ESI-MS + MS/MS on request) so the data below carries through to the COA you receive.
| Sequence | Vial Sizes | ||||
|---|---|---|---|---|---|
| BPC-157 | 137525-51-0 | 1419.55 | GEPPPGKP… | ≥ 99.0% | 2 / 5 / 10 mg |
| CJC-1295 (no DAC) | 863288-34-0 | — | — | ≥ 99.0% | 2 / 5 / 10 mg |
| CJC-1295 + Ipamorelin | — | — | — | ≥ 99.0% per component | 10 mg |
| Epitalon | 307297-39-8 | — | AEDG | ≥ 99.0% | 10 / 50 mg |
| Ipamorelin | 170851-70-4 | — | — | ≥ 99.0% | 2 / 5 / 10 mg |
| KPV | 67727-97-3 | — | KPV | ≥ 99.0% | 5 / 10 mg |
| MOTS-c | 1627580-64-6 | — | MRWQEMGY… | ≥ 99.0% | 10 / 15 / 20 / 40 mg |
| NAD+ | 53-84-9 | — | — | ≥ 99.0% | 100 / 500 / 1000 mg |
| Semax | 80714-61-0 | — | MEHFPGP | ≥ 99.0% | 2 / 5 / 10 / 15 mg |
| TB-500 | 885340-08-9 | — | SDKPDMAE… | ≥ 99.0% | 2 / 5 / 10 mg |
- BPC-157
- CAS
- 137525-51-0
- MW
- 1419.55
- Purity
- ≥ 99.0%
- Seq
- GEPPPGKP…
- Vials
- 2 / 5 / 10 mg
- CJC-1295 (no DAC)
- CAS
- 863288-34-0
- MW
- —
- Purity
- ≥ 99.0%
- Seq
- —
- Vials
- 2 / 5 / 10 mg
- CJC-1295 + Ipamorelin
- CAS
- —
- MW
- —
- Purity
- ≥ 99.0% per component
- Seq
- —
- Vials
- 10 mg
- Epitalon
- CAS
- 307297-39-8
- MW
- —
- Purity
- ≥ 99.0%
- Seq
- AEDG
- Vials
- 10 / 50 mg
- Ipamorelin
- CAS
- 170851-70-4
- MW
- —
- Purity
- ≥ 99.0%
- Seq
- —
- Vials
- 2 / 5 / 10 mg
- KPV
- CAS
- 67727-97-3
- MW
- —
- Purity
- ≥ 99.0%
- Seq
- KPV
- Vials
- 5 / 10 mg
- MOTS-c
- CAS
- 1627580-64-6
- MW
- —
- Purity
- ≥ 99.0%
- Seq
- MRWQEMGY…
- Vials
- 10 / 15 / 20 / 40 mg
- NAD+
- CAS
- 53-84-9
- MW
- —
- Purity
- ≥ 99.0%
- Seq
- —
- Vials
- 100 / 500 / 1000 mg
- Semax
- CAS
- 80714-61-0
- MW
- —
- Purity
- ≥ 99.0%
- Seq
- MEHFPGP
- Vials
- 2 / 5 / 10 / 15 mg
- TB-500
- CAS
- 885340-08-9
- MW
- —
- Purity
- ≥ 99.0%
- Seq
- SDKPDMAE…
- Vials
- 2 / 5 / 10 mg
All entries supplied for Research Use Only (RUO) and sold exclusively to qualified academic, biotech R&D, and CRO buyers. See the B2B / RUO policy.
Lot Report · Excerpt
TB-500 · Lot LC-26-B0312
- RP-HPLC purity
- 98.94 %
- ESI-MS [M+H]⁺
- 4961.4 Da
- MS/MS sequence
- Confirmed
- Water (KF)
- 5.2 %
- Counter-ion
- Acetate
- Stability (12 mo)
- ≥ 97 % retained
The lot report is the document you reference in your supplementary materials and your supplier-qualification file. Every release carries the same scope.
Illustrative lot report excerpt · TB-500 lot LC-26-B0312 · representative scope released with every shipment
Quality you can verify
Lot data first. Sales second.
Every Lyochem lot is released with its own analytical packet — chromatogram, mass spectrum, sequence confirmation, water content, stability. Methods are aligned with USP <1225>, EP, and ICH Q2 — the document a paper reviewer or CRO QA team can read directly off the page.
≥98.5%
HPLC purity floor
MS/MS
Sequence verified
12-mo
-20 °C stability
RP-HPLC + ESI-MS on every release, integrated purity reported at the main retention time, mass within ± 0.5 Da of theoretical.
LC-MS/MS sequence on request — b- and y-ion ladder assignment against the theoretical sequence; full-ladder coverage reported on the data packet.
−20 °C stability programme through 12 months; accelerated 40 °C add-ons on request for first-time supplier qualification.
Lab Notes
Methodology briefs from the bench.
Short methodology briefs aimed at bench scientists and CRO QA teams. Where the catalogue answers “what is the standard?”, the lab note answers “how do I read its data?”.
Request a data packet.
First reply under 12 hours from a synthesis chemist or analytical contact — not a templated auto-response. Lot-specific HPLC chromatogram, ESI-MS identity, MS/MS sequence (on request), KF water, and stability data returned with the quote.